Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Der Internist|February 2, 2013
[Breast cancer. Individualized therapy concepts]N Harbeck, R Wuerstlein
Breast (Edinburgh, Scotland)|December 30, 2014
Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer RegistryT Kolben, N Harbeck, R Wuerstlein, et al.
Archives of Gynecology and Obstetrics|March 28, 2026
Tumor biology, treatment patterns, and recurrence in breast cancer patients aged 70-79 vs ≥ 80 years: a large-scale registry analysisF Ganster, S Schrodi, M Braun, et al.
International Journal of Surgery (London, England)|October 10, 2015
Surgical management of ipsilateral breast tumor recurrenceT Kolben, T M Schwarz, C Goess, et al.
Breast Cancer Research and Treatment|December 9, 2015
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancerThomas Kolben, D Augustin, R Armbrust, et al.
Archives of Gynecology and Obstetrics|February 12, 2025
Influence of breast cancer on life satisfaction in the elderly patientM Burgmann, K Hermelink, A Lotz, et al.
Breast Cancer Research and Treatment|March 31, 2021
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancerH Helbrich, M Braun, C Hanusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial<sup>☆</sup>F Montemurro, S Delaloge, C H Barrios, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015M Untch, D Augustin, J Ettl, et al.
Breast Cancer Research and Treatment|February 24, 2019
Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe studyR Wuerstlein, R Kates, O Gluz, et al.
Pageof 3